While TMB was low, the genomic landscape of AM was characterized by a high level of CNV, which was commonly found in CCND1 (19.3%), CDK4 (19.3%), MDM2 (14.5%) and FGF19 (12%). The gene discussed is MDM2; the disease is acute myeloblastic leukemia with maturation.